Activase and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Activase (alteplase) and Emla (lidocaine; prilocaine). Common drug interactions include abdominal discomfort among females and alcohol abuse among males.

The phase IV clinical study analyzes what interactions people have when they take Activase and Emla. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Activase?

Activase has active ingredients of alteplase. eHealthMe is studying from 7,526 Activase users. Check the latest studies of Activase.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.



On Jul, 13, 2026

24 people who take Activase and Emla together, and have interactions are studied.

Activase and Emla drug interactions.

What are the common drug interactions of Activase and Emla, by gender? *:

female:

  1. Abdominal discomfort
  2. Headache (pain in head)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Blood calcium decreased
  5. Constipation
  6. Decreased appetite
  7. Dry skin
  8. Dysgeusia (disorder of the sense of taste)
  9. Dyspepsia (indigestion)
  10. Emotional distress

male:

  1. Alcohol abuse
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Failure to thrive (inadequate weight gain and physical growth in children)
  6. Hyperchloraemia (an excess of chlorides in the blood)
  7. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  8. Hypokalaemia (low potassium)
  9. Hypophagia (reduced food intake)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Activase and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arrhythmia (irregular heartbeat)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypotension (abnormally low blood pressure)
  4. Right ventricular failure (right half of the heart fails to work)

20-29:

n/a

30-39:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

  1. Alcohol abuse
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Lung abscess (pus in lungs)

50-59:

  1. Hypokalaemia (low potassium)
  2. Plasma cell myeloma (cancer that begins in plasma cells)

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Blood calcium decreased
  3. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  4. Heart rate increased
  5. Leukaemia recurrent (repeat cancer of bone marrow or blood cells)
  6. Nausea (feeling of having an urge to vomit)
  7. Oesophageal stenosis (narrowing of oesophagus)
  8. Peripheral swelling
  9. Rectal haemorrhage (bleeding from anus)
  10. Stomatitis (inflammation of mucous membrane of mouth)

What are the existing conditions these people have? *

  1. Pain: 9 people, 37.50%
  2. Ovarian Cancer (cancer of ovary): 8 people, 33.33%
  3. Nausea (feeling of having an urge to vomit): 5 people, 20.83%
  4. Constipation: 5 people, 20.83%
  5. Nausea And Vomiting: 4 people, 16.67%
  6. Insomnia (sleeplessness): 4 people, 16.67%
  7. Indigestion: 3 people, 12.50%
  8. High Blood Pressure: 3 people, 12.50%
  9. Stress And Anxiety: 2 people, 8.33%
  10. Fungal Infection: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Activase and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Activase and Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Activase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Activase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alteplase and lidocaine; prilocaine (the active ingredients of Activase and Emla, respectively), and Activase and Emla (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: